These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Comparison of interventions for intermediate to high-risk pulmonary embolism: A network meta-analysis. Ishisaka Y, Watanabe A, Fujisaki T, Iwagami M, So M, Steiger D, Aoi S, Secemsky EA, Wiley J, Kuno T. Catheter Cardiovasc Interv; 2023 Aug; 102(2):249-265. PubMed ID: 37269229 [Abstract] [Full Text] [Related]
8. Safety and efficacy of clot-dissolving therapies for submassive pulmonary embolism: A network meta-analysis of randomized controlled trials. Al Hennawi H, Khedr A, Khan MK, Ashraf MT, Sohail A, Mathbout L, Eissa A, Mathbout M, Klugherz B. Cardiovasc Revasc Med; 2024 May 13; 62():73-81. PubMed ID: 38176962 [Abstract] [Full Text] [Related]
12. Systemic Thrombolysis, Catheter-Directed Thrombolysis, and Anticoagulation for Intermediate-risk Pulmonary Embolism: A Simulation Modeling Analysis. Kabrhel C, Ali A, Choi JG, Hur C. Acad Emerg Med; 2017 Oct 13; 24(10):1235-1243. PubMed ID: 28650086 [Abstract] [Full Text] [Related]